Objectives: A systematic review and meta-analysis (SR-MA) of the available Indian literature
on severe vivax malaria (SVM) was undertaken. Methods: Relevant studies in eight …

Background Plasmodium vivax, once considered benign species, is recently being
recognised to be causing severe malaria like Plasmodium falciparum. In the present study …

Background Under-reporting, delayed diagnosis, incomplete treatment and inadequate
vector management are few among many factors responsible for uninterrupted transmission …

The aim of this study was to assess the clinical profile, severity and complications of patients
suffering from malaria in Mangaluru, a southwestern coastal city in India. A total of 579 …

In most of India, sulfadoxine–pyrimethamine (SP) plus artesunate serves as first-line
treatment for uncomplicated falciparum malaria. In 112 clinical Plasmodium falciparum …

Background Duffy blood group antigens serve as receptors for Plasmodium vivax invasion
into erythrocytes, and they are determined by polymorphisms of the Duffy antigen receptor …

India accounts for approximately half of the global Plasmodium vivax cases, but information
as to the presence of chloroquine (CQ) resistance is scarce. In an observational study in …

India faces 0.5 million malaria cases annually, including half of all Plasmodium vivax
malaria cases worldwide. This case–control study assessed socioeconomic determinants of …

Micro-RNAs (miRNAs) play a crucial role in immune regulation, and a common miRNA-146a
polymorphism (rs2910164) increased the odds of falciparum malaria in pregnant African …

Antimalarial drug efficacy is monitored through various methods in vivo and in vitro. The in
vivo methods include therapeutic efficacy studies (TES) which track clinical and …